DrugPatentWatch Database Preview
Off-Patent Drugs With 4 Sources
This table lists drugs which, despite having no patents or regulatory protections, have a limited number of sources.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Strength |
|---|---|---|---|---|---|---|---|---|---|---|
| Barr Labs Div Teva | ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 200143-001 | Nov 18, 2013 | AB | RX | No | No | 333MG |
| Glenmark Generics | ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 202229-001 | Jul 16, 2013 | AB | RX | No | Yes | 333MG |
| Mylan Pharms Inc | ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 200142-001 | Mar 11, 2014 | AB | RX | No | No | 333MG |
| Zydus Pharms Usa Inc | ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 205995-001 | May 26, 2017 | AB | RX | No | No | 333MG |
| Amneal Pharm | ACEBUTOLOL HYDROCHLORIDE | acebutolol hydrochloride | CAPSULE;ORAL | 075047-001 | Dec 30, 1999 | AB | RX | No | Yes | EQ 200MG BASE |
| Amneal Pharm | ACEBUTOLOL HYDROCHLORIDE | acebutolol hydrochloride | CAPSULE;ORAL | 075047-002 | Dec 30, 1999 | AB | RX | No | Yes | EQ 400MG BASE |
| Mylan | ACEBUTOLOL HYDROCHLORIDE | acebutolol hydrochloride | CAPSULE;ORAL | 074288-001 | Apr 24, 1995 | AB | RX | No | No | EQ 200MG BASE |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Strength |
